Acetylon Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile
April 2017
20
About the Report
About the Report
Acetylon Pharmaceuticals Inc (Acetylon) is a pharmaceutical company that discovers and develops next-generation selective small molecule histone deacetylase inhibitors and selective small molecule drugs. The company treat patients suffering from critical and unmet medical needs. It offers products for the treatment of cancers, including multiple myeloma, neurodegenerative, inflammatory, metabolic, and genetic and infectious parasitic diseases. Acetylon also provides clinical trials, higher dosing, extended administration, reduction of combination drug toxicity, enhanced therapeutic benefit services, and medical research and development services. The company's therapeutic areas include Ricolinostat and ACY-241 in other cancers and non-oncology indications. Acetylon is headquartered in Boston, Massachusetts, the US.
Acetylon Pharmaceuticals Inc-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
Business Description-A brief description of the company's operations.
Key Employees-A list of the key executives of the company.
Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
Key Competitors-A list of the key competitors of the company.
Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Acetylon Pharmaceuticals Secures USD100 Million in Fundnig from Celgene 10
Acetylon Pharma Raises US$15 Million From Celgene 10
Acetylon Pharma Raises Additional US$15.2 Million In Series B Financing 12
Partnerships 13
Hereditary Neuropathy Foundation Partners with Acetylon Pharma 13
Acetylon Pharma Enters Into Co-Development Agreement With Leukemia & Lymphoma Society 13
Licensing Agreements 14
Regenacy Pharma Receives Rights to HDAC6 Inhibitor, Ricolinostat ACY-1215 from Acetylon Pharma 14
Acquisition 15
Celgene to Acquire Acetylon Pharma 15
Acetylon Pharmaceuticals Inc-Key Competitors 17
Key Employees 18
Locations And Subsidiaries 19
Head Office 19
Appendix 20
Methodology 20
About GlobalData 20
Contact Us 20
Disclaimer 20
List of Figure
List of Figures
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 1
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 1
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 1
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 1
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
List of Table
List of Tables
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 1
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Acetylon Pharmaceuticals Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Acetylon Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Acetylon Pharmaceuticals Secures USD100 Million in Fundnig from Celgene 10
Acetylon Pharma Raises US$15 Million From Celgene 10
Acetylon Pharma Raises Additional US$15.2 Million In Series B Financing 12
Hereditary Neuropathy Foundation Partners with Acetylon Pharma 13
Acetylon Pharma Enters Into Co-Development Agreement With Leukemia & Lymphoma Society 13
Regenacy Pharma Receives Rights to HDAC6 Inhibitor, Ricolinostat ACY-1215 from Acetylon Pharma 14
Celgene to Acquire Acetylon Pharma 15
Acetylon Pharmaceuticals Inc, Key Competitors 17
Acetylon Pharmaceuticals Inc, Key Employees 18
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.